Subscribe

What are you looking for?

Main Menu

明報新聞網

兆科眼科老花眼創新藥獲澳門藥監局批准 擬進入大灣區市場

Future Wealths
Future Wealths
20 7 月, 2026
One Min Read
1 Views
0 Comments
兆科眼科（6622）宣佈，於7月13日旗下老花眼創新藥物YUVEZZITM（卡巴膽堿/酒石酸溴莫尼丁滴眼液）取得澳門政府藥物監督管理局的監管批准。在前一個月即6月份，集團亦獲得海南省藥品監督管理局（海南藥監局）的監管批准，YUVEZZITM獲批准作為臨床急需進口藥物在博鰲超級醫院使用。

原文: https://finance.mingpao.com/fin/instantf/20260720/1784545253109/%E5%85%86%E7%A7%91%E7%9C%BC%E7%A7%91%E8%80%81%E8%8A%B1%E7%9C%BC%E5%89%B5%E6%96%B0%E8%97%A5%E7%8D%B2%E6%BE%B3%E9%96%80%E8%97%A5%E7%9B%A3%E5%B1%80%E6%89%B9%E5%87%86-%E6%93%AC%E9%80%B2%E5%85%A5%E5%A4%A7%E7%81%A3%E5%8D%80%E5%B8%82%E5%A0%B4%22%20target=%22blank

Last Update: 20 7 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept